measuregroup/AID385190

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103554720_AID385190_PMID18412317_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID104234199_AID385190_PMID18412317_VALUE6 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103541455_AID385190_PMID18412317_VALUE2 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103292372_AID385190_PMID18412317_VALUE1 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103556348_AID385190_PMID18412317_VALUE4 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103621604_AID385190_PMID18412317_VALUE5
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10116 http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1969
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title	Safety index, ratio of ED50 for inhibition of hepatic cholesterol synthesis in Sprague-Dawley rat to drug dose not causing >2.5 fold increase in plasma creatine kinase level in weanling Sprague-Dawley rat
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103292372 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103621604 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID104234199 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103554720 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103556348 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103541455
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID385190

Total number of triples: 18.